EOLS - Evolus Inc Stock Price, Fair Value and News

$6.75+0.23 (+3.53%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

EOLS Price Action

Last 7 days

-4.1%

Last 30 days

5.6%

Last 90 days

-10.1%

Trailing 12 Months

-48.5%

EOLS RSI Chart

EOLS Valuation

Market Cap

437.5M

Price/Earnings (Trailing)

-7.47

Price/Sales (Trailing)

1.53

EV/EBITDA

-14.51

Price/Free Cashflow

-8.3

EOLS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

EOLS Fundamentals

EOLS Revenue

Revenue (TTM)

285.8M

Rev. Growth (Yr)

12.9%

Rev. Growth (Qtr)

-0.61%

EOLS Earnings

Earnings (TTM)

-58.6M

Earnings Growth (Yr)

17.91%

Earnings Growth (Qtr)

8.2%

EOLS Profitability

EBT Margin

-20.23%

Return on Equity

203.62%

Return on Assets

-26.74%

Free Cashflow Yield

-12.04%

EOLS Investor Care

Shares Dilution (1Y)

2.37%

Diluted EPS (TTM)

-0.91

EOLS Alerts

Losses in recent quarter

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	275.5M	277.9M	285.8M	0
2024	219.7M	237.3M	248.3M	266.3M
2023	156.4M	168.6M	184.7M	202.1M
2022	121.3M	132.4M	139.6M	148.6M
2021	58.3M	76.6M	85.6M	99.7M
2020	40.3M	45.7M	51.1M	56.5M
2019	0	0	0	34.9M

Get all data in R, Python etc through our Historical Stock Data APIs

About Evolus Inc

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

CEO	Mr. David Moatazedi
WEBSITE	evolus.com
SECTOR	Healthcare
INDUSTRY	Drug Manufacturers Specialty & Generic
EMPLOYEES	215

Evolus Inc Frequently Asked Questions

What is the ticker symbol for Evolus Inc? What does EOLS stand for in stocks?

EOLS is the stock ticker symbol of Evolus Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Evolus Inc (EOLS)?

As of Wed Dec 03 2025, market cap of Evolus Inc is 437.53 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EOLS stock?

You can check EOLS's fair value in chart for subscribers.

Is Evolus Inc a good stock to buy?

The fair value guage provides a quick view whether EOLS is over valued or under valued. Whether Evolus Inc is cheap or expensive depends on the assumptions which impact Evolus Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EOLS.

What is Evolus Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, EOLS's PE ratio (Price to Earnings) is -7.47 and Price to Sales (PS) ratio is 1.53. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EOLS PE ratio will change depending on the future growth rate expectations of investors.